Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
240104_PR_COVA_publication_in_EBI
By
admin
January 4, 2024
231229_PR_Drawing_4th_tranche_Atlas_Contract
By
admin
December 29, 2023
231229_CP_Tirage_4e_tranche_contrat_Atlas
By
admin
December 29, 2023
231211_PR_Conference_participation_Q1_2024
By
admin
December 11, 2023
231211_CP_Participation_Conferences_T1_2024
By
admin
December 11, 2023
231204_PR_Liege_University_Partnership
By
admin
December 4, 2023
231204_CP_Partenariat_Universite_de_Liege
By
admin
December 4, 2023
231127_PR_Appointments_Scientific_Advisory_Board
By
admin
November 27, 2023
231127_CP_Nominations_Comite_Scientifique
By
admin
November 27, 2023
112023_PR_Successful_capital_increase_EN
By
admin
November 19, 2023
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
…
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
